Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer
Andrew D. Seidman(Memorial Sloan Kettering Cancer Center), Alison Conlin(Providence Portland Medical Center), Ariadne M. Bach(Memorial Sloan Kettering Cancer Center), Mary Ellen Moynahan(Memorial Sloan Kettering Cancer Center), Diana Lake(Memorial Sloan Kettering Cancer Center), Andres Forero(University of Alabama at Birmingham), Gail S. Wright(Florida Cancer Specialists & Research Institute), Mary Helen Hackney(Virginia Commonwealth University), Alicia Clawson, Larry Norton(Memorial Sloan Kettering Cancer Center), Clifford A. Hudis(Memorial Sloan Kettering Cancer Center)
Cited by 32
Abstract
Related Papers
No related papers found
Powered by citation graph analysis